Xiaohong Mao
Impact in
- Molecular Biology top 1%
- Cell death mechanisms and regulation
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA Interference and Gene Delivery
- Wnt/β-catenin signaling in development and cancer
- Genomics and Chromatin Dynamics
- RNA modifications and cancer
- Immunology top 2%
- Immune Cell Function and Interaction
Papers in
- Oncology 9
- Vascular Tumors and Angiosarcomas 2
- Co-authors
- Craig B. ThompsonLawrence BoiseTullia LindstenGabriel NúñezLaurence A. TurkaLi-Yun DingMaribel González‐GarcíaStuart H. Orkin
- Journals
- Journal of Clinical Investigation (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular and Cellular Biology (2 papers)Blood (2 papers)The Science of The Total Environment (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Xiaohong Mao
37 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Molecular Biology 4.8k
- Immunology 1.3k
- Cancer Research 751
- Oncology 1.1k
- Developmental Neuroscience 129
Countries citing papers authored by Xiaohong Mao
This map shows the geographic impact of Xiaohong Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Mao more than expected).
Fields of papers citing papers by Xiaohong Mao
This network shows the impact of papers produced by Xiaohong Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Mao. The network helps show where Xiaohong Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaohong Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 19 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 54 | |
| 8 | 2021 | 25 | |
| 9 | 2017 | 36 | |
| 10 | 2012 | 11 | |
| 11 | 2012 | 9 | |
| 12 | [Electrophysiological changes in diabetic peripheral neuropathy patients of different Chinese medicine syndrome types intervened by naoxintong and mecobalamin]. | 2011 | 4 |
| 13 | 2010 | 12 | |
| 14 | 2008 | 268 | |
| 15 | EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency Hit paper breakdown → | 2008 | 781 |
| 16 | 2005 | 40 | |
| 17 | 2005 | 68 | |
| 18 | 1994 | 90 | |
| 19 | 1993 | 202 | |
| 20 | bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death Hit paper breakdown → | 1993 | 2684 |
About Xiaohong Mao
Xiaohong Mao is a scholar working on Oncology, Pharmaceutical Science, Molecular Biology, Immunology and Cancer Research, having authored 40 papers that have together received 6.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Epigenetics and DNA Methylation (5 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related gene regulation (3 papers), Genomics and Chromatin Dynamics (3 papers), RNA modifications and cancer (3 papers), T-cell and B-cell Immunology (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Molecular Biology (4.8k citations), Immunology (1.3k citations), Cancer Research (751 citations), Oncology (1.1k citations) and Developmental Neuroscience (129 citations). Xiaohong Mao has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Craig B. Thompson, Lawrence Boise, Tullia Lindsten, Gabriel Núñez, Laurence A. Turka, Li-Yun Ding, Maribel González‐García, Stuart H. Orkin, Yuko Fujiwara and Xiaohua Shen. Their work appears in journals such as Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, Molecular and Cellular Biology, Blood and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.